Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 μg of ethinyl estradiol and 3 mg of drospirenone
- 31 December 2006
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 74 (6), 451-457
- https://doi.org/10.1016/j.contraception.2006.07.004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Contraceptive efficacy, compliance and beyond: Factors related to satisfaction with once-weekly transdermal compared with oral contraceptionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
- Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trialContraception, 2005
- The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra®) on contraceptive efficacyContraception, 2004
- Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ringObstetrics & Gynecology, 2002
- Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiolAmerican Journal of Obstetrics and Gynecology, 2002
- Oral Contraceptives: Current StatusClinical Obstetrics and Gynecology, 2001
- Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiolHuman Reproduction, 2001
- Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal RingClinical Pharmacokinetics, 2000
- Causes and consequences of oral contraceptive noncomplianceAmerican Journal of Obstetrics and Gynecology, 1999
- Oral contraceptive discontinuation: A prospective evaluation of frequency and reasonsAmerican Journal of Obstetrics and Gynecology, 1998